Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention | Zendy

Thomas Zanchin | Zendy; Lorenz Räber | Zendy; Konstantinos C. Koskinas | Zendy; Raffaele Piccolo | Zendy; Peter Jüni | Zendy; Thomas Pilgrim | Zendy; Stefan Stortecky | Zendy; Ahmed A. Khattab | Zendy; Peter Wenaweser | Zendy; Stefan Bloechlinger | Zendy; Aris Moschovitis | Zendy; Andrè Frenk | Zendy; Christina Moro | Zendy; Bernhard Meier | Zendy; Martin Fiedler | Zendy; Dik Heg | Zendy; Stephan Windecker | Zendy

Open Access

Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention

Author(s) -

Thomas Zanchin,

Lorenz Räber,

Konstantinos C. Koskinas,

Raffaele Piccolo,

Peter Jüni,

Thomas Pilgrim,

Stefan Stortecky,

Ahmed A. Khattab,

Peter Wenaweser,

Stefan Bloechlinger,

Aris Moschovitis,

Andrè Frenk,

Christina Moro,

Bernhard Meier,

Martin Fiedler,

Dik Heg,

Stephan Windecker

Publication year - 2016

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.115.003202

Subject(s) - medicine , hazard ratio , scad , percutaneous coronary intervention , cardiology , confidence interval , troponin complex , coronary artery disease , troponin t , troponin , myocardial infarction

Cardiac troponin detected by new-generation, highly sensitive assays predicts clinical outcomes among patients with stable coronary artery disease (SCAD) treated medically. The prognostic value of baseline high-sensitivity cardiac troponin T (hs-cTnT) elevation in SCAD patients undergoing elective percutaneous coronary interventions is not well established. This study assessed the association of preprocedural levels of hs-cTnT with 1-year clinical outcomes among SCAD patients undergoing percutaneous coronary intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research